Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.4901
0.00 (0.00%)
At close: Mar 12, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $887.18 thousand as of March 16, 2026.
Market Cap
887.18K
Enterprise Value
2.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.49
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 887.18K, a decrease of -90.80%. That is a compound annual growth rate of -94.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 887.18K | -64.73% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halberd | 1.12M |
| CERo Therapeutics Holdings | 1.10M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 1.02M |
| EV Biologics | 848.71K |
| THC Farmaceuticals | 834.05K |
| Lipella Pharmaceuticals | 808.65K |
| Avenue Therapeutics | 790.71K |